Literature DB >> 28852373

Advances in the Treatment of Hepatitis B and Hepatitis C Nonresponders: A Report of Symposia Presented at the 15th Conference of the Asian Pacific Association for the Study of the LiverAugust 18-21, 2005Bali, Indonesia.

.   

Abstract

Entities:  

Year:  2006        PMID： 28852373      PMCID： PMC5565914     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  38 in total

1.  Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level.

Authors:  C Giuliani; G Napolitano; A Mastino; S Di Vincenzo; C D'Agostini; S Grelli; I Bucci; D S Singer; L D Kohn; F Monaco; E Garaci; C Favalli
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

2.  Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B.

Authors:  L Zhuang; J You; B Z Tang; S Y Ding; K H Yan; D Peng; Y M Zhang; L Zhang
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  A randomized controlled clinical trial on the treatment of Thymosin a1 versus interferon-alpha in patients with hepatitis B.

Authors:  J You; L Zhuang; B Z Tang; W B Yang; S Y Ding; W Li; R X Wu; H L Zhang; Y M Zhang; S M Yan; L Zhang
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

4.  The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis.

Authors:  H L Chan; J L Tang; W Tam; J J Sung
Journal:  Aliment Pharmacol Ther       Date:  2001-12       Impact factor: 8.171

5.  Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Authors:  Y F Liaw; N W Leung; T T Chang; R Guan; D I Tai; K Y Ng; R N Chien; J Dent; L Roman; S Edmundson; C L Lai
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

6.  In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

Authors:  P Andreone; C Cursaro; A Gramenzi; M Margotti; E Ferri; S Talarico; M Biselli; F Felline; C Tuthill; E Martins; G Gasbarrini; M Bernardi
Journal:  J Viral Hepat       Date:  2001-05       Impact factor: 3.728

7.  A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B.

Authors:  C Zavaglia; R Severini; C Tinelli; J S Franzone; A Airoldi; S Tempini; G Bettale; G Ideo
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

8.  Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.

Authors:  M G Mutchnick; K L Lindsay; E R Schiff; G D Cummings; H D Appelman; R R Peleman; M Silva; K C Roach; F Simmons; S Milstein; S C Gordon; M N Ehrinpreis
Journal:  J Viral Hepat       Date:  1999-09       Impact factor: 3.728

Review 9.  Profound suppression of hepatitis B virus replication with lamivudine.

Authors:  C L Lai; M F Yuen
Journal:  J Med Virol       Date:  2000-07       Impact factor: 2.327

10.  Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.

Authors:  Murat Saruc; Hakan Yuceyar; Nurten Kucukmetin; Mehmet Akif Demir; Ali Riza Kandiloglu
Journal:  Hepatogastroenterology       Date:  2002 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.